Very recently, CB Insights published something they called the Periodic Table of Healthcare.   It was a very clever way to characterize the healthcare landscape, featuring investors, acquirers in pharma, biotech, medical devices, drug discovery, drug development.  They specifically noted that the Table was not intended to characterize the digital health world, so I decided to […]